Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
The American Journal of Surgical Pathology|November 29, 2007
Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologistsBing Cai, Brigitte M Ronnett, Mark Stoler, et al.
The Journal of Infectious Diseases|October 24, 2007
Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccineAnna R Giuliano, Eduardo Lazcano-Ponce, Luisa Villa, et al.
Obstetrics and Gynecology|January 6, 2006
Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trialConstance Mao, Laura A Koutsky, Kevin A Ault, et al.
Mayo Clinic Proceedings|May 13, 2005
Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trialGregory A Poland, Robert M Jacobson, Laura A Koutsky, et al.
Gastroenterology|February 15, 2017
Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated AnalysisIra M Jacobson, Eric Lawitz, Paul Y Kwo, et al.
Journal of Gastroenterology|January 19, 2018
The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infectionStefan Zeuzem, Lawrence Serfaty, John Vierling, et al.
Vaccine|August 7, 2004
A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccineKevin A Ault, Anna R Giuliano, Robert P Edwards, et al.
The American Journal of Gastroenterology|April 27, 2018
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trialsPhilippe J Zamor, John Vierling, Reem Ghalib, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2018
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: A pooled analysisTarik Asselah, Hendrik Reesink, Jan Gerstoft, et al.
The Pediatric Infectious Disease Journal|December 3, 2009
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccineStan L Block, Darron R Brown, Archana Chatterjee, et al.
Pageof 8